Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

A veterinarian vaccinates an Egyptian vulture against avian influenza at the Mulhouse zoo, eastern France, in 2020. Moderna had been developing a vaccine to combat an outbreak of bird flu in dairy ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

Bird flu is spreading on farms and infecting people. If the current response to the virus is a trial run in pandemic preparedness, we've failed it.